Talphera (TLPH) Acquisitions (2021 - 2022)

Talphera's (TLPH) quarterly Acquisitions came in at $531000.0 in Q2 2022, down 54.07% quarter-over-quarter from $1.2 million in Q1 2022.

Talphera (TLPH) Acquisitions (2021 - 2022) Analysis & Trends

Talphera's Acquisitions history runs 2 years deep, the most recent figure standing at $531000.0 for Q2 2022.

On a quarterly basis, Acquisitions changed N/A year-over-year to $531000.0 in Q2 2022; TTM through Mar 2023 was $531000.0, a 73.14% decrease from a year earlier, with the FY2022 full-year figure at $1.7 million, up 105.48% from the prior year.
Acquisitions retreated to $531000.0 in Q2 2022 per TLPH's latest filing, from $1.2 million in the prior quarter.
Across five years, Acquisitions topped out at $1.2 million in Q1 2022 and bottomed at $531000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Talphera	47.31 Mn	9.48 Mn	-	-

Download Data